A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis

✍ Scribed by Michael J. Borucki; John Spritzler; David M. Asmuth; John Gnann; Martin S. Hirsch; Mostafa Nokta; Francesca Aweeka; Paul I. Nadler; Fred Sattler; Beverly Alston; Thomas T. Nevin; Susan Owens; Karen Waterman; Larry Hubbard; Angela Caliendo; Richard B. Pollard

• Book ID: 113457158
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 152 KB
• Volume: 64
• Category: Article
• ISSN: 0166-3542
• DOI: 10.1016/j.antiviral.2004.06.012